Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer

57

Citations

25

References

2013

Year

Robert J. Jones, Jacqueline Vuky, Tony Elliott, Graham M. Mead, José Ángel Arranz, John Chester, Simon Chowdhury, Arkadiusz Z. Dudek, V. Müller-Mattheis, Marc‐Oliver Grimm,

Investigational New Drugs

UrologyGenitourinary CancerMedicinePhase Ii StudyCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1